Anne Musters Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

1/2015

Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Musters Research Topics

Disease

2	Rheumatoid Arthritis 01/2019 - 01/2015
1	Mevalonate Kinase Deficiency 10/2015
1	Hereditary Autoinflammatory Diseases 10/2015
1	Fever (Fevers) 10/2015
1	Castleman Disease (Castleman's Disease) 01/2015
1	Multi-centric Castleman's Disease 01/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015

Drug/Important Bio-Agent (IBA)

2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2015 - 01/2015
1	Pharmaceutical PreparationsIBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	Immunoglobulin D (IgD)IBA 10/2015
1	Immunomodulating AgentsIBA 01/2015
1	tocilizumab (atlizumab)FDA Link 01/2015

Therapy/Procedure

1	Therapeutics 10/2015
1	Investigational Therapies (Experimental Therapy) 01/2015